SOURCE: NanoViricides, Inc.

October 03, 2007 15:26 ET

Update: NanoViricides CEO Interview Moved to 2:30

WEST HAVEN, CT--(Marketwire - October 3, 2007) - The Interview with Dr. Eugene Seymour, CEO of NanoViricides (OTCBB: NNVC), has been changed to 2:30PM C.D.T. on Market News First www.mn1.com slated for today October 3, 2007. Seymour will be talking with the MN1 news team about key Company developments.

To learn more about NanoViricides and how it is changing the marketplace, log on www.mn1.com on October 3, 2007 at 2:30PM CDT.

About NanoViricides:

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H5N1 bird flu, seasonal influenza, HIV, hepatitis C, rabies, dengue fever, among others.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors including the availability of adequate financing, the success of the Company's research and development strategy, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process, described in the "Management's Discussion and Analysis" section of the Company's Form 10-KSB and other reports and filings with the Securities and Exchange Commission. Such risks, uncertainties and other factors may cause actual results, performance, or achievements of the Company to be different from those expressed or implied by the Company.

(www.nanoviricides.com)

About MN1.com

Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live radio website that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

Through daily, live interviews, Market News First brings you up to date on all the well-respected and established companies and informs investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask. This service provides them with insight into the companies' present condition and future plans.

Contact Information

  • Contact:
    Angela Junell
    Market News First
    214-461-3411